Skip to content

Water Immersion in Right-Sided Heart Failure: A Pilot Study

Water Immersion in Right-Sided Heart Failure: A Pilot Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00654264
Enrollment
13
Registered
2008-04-07
Start date
2007-12-31
Completion date
2009-12-31
Last updated
2022-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Right Sided Cardiac Failure

Brief summary

This is an unblinded pilot study comparing (against a randomized control day without water immersion) the diuretic and natriuretic effects of water immersion in patients with right heart failure.

Detailed description

Patients will be immersed in a tub for 3 hours (on one day) and neurohormones will be obtained before and after immersion. Urine will be collected for quantification and evaluation of sodium concentration.

Interventions

Subjects will sit in tub for four hours.

Sponsors

University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must have right sided failure secondary to right ventricular dysfunction, pulmonary hypertension, or tricuspid regurgitation * Age greater than 18 years of age * Right heart catheterization within the last year to rule out left-sided failure. * Evidence of fluid overload as indicated by 2 or more of the following: 1.) 2+ or more pitting edema of the lower extremities, 2.) scrotal or penile edema, 3.) JVP greater than or equal to 10 cm, 4.) abdominal ascites

Exclusion criteria

* Pulmonary capillary wedge pressure above 16 mmHg or history of elevated left ventricular filling pressures. * Serum creatinine \> 2.0 * Current use of an angiotensin I converting enzyme inhibitor or angiotensin receptor blocker will preclude participation in the RAS neurohormone portion of the study.

Design outcomes

Primary

MeasureTime frame
Diuresis4 hours

Secondary

MeasureTime frame
Neurohormonal activation4 hours
Natriuresis4 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026